Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFS |
Texto Completo: | https://ri.ufs.br/handle/riufs/3679 |
Resumo: | Coronary heart disease (CHD) is one of the main causes of death in the world and Framingham Risk Score (FRS) is the most used tool to assess the risk of CHD in asymptomatic patients. However, it underestimates the cardiovascular (CDV) risk in some individuals. To address this problem, Brazilian Society of Cardiology proposes further risk stratification tests, using emerging risk factors - known as aggravating risk factors - that, when present, reclassify the risk category to a higher one than that initially estimated by the FRS. One does not know which of these aggravating risk factors have more influence in this reclassification, nor the frequency of each CDV risk category after their use and its financial cost. In an observational, descriptive study, 66 patients (54,8 ± 13,9 years, 33 men and 33 women) from a private clinic at Aracaju, Sergipe, had been evaluated during their routine medical exams. Forty three (65.2%) patients were at low-risk category and 23 (34.8%) at the intermediate risk. All of them had been submitted to the screening of the following aggravating risk factors: familiar history of premature CHD (FHCHD), metabolic syndrome (MS), left ventricular hypertrophy (LVH), high sensitivity C reactive protein (CPRus), chronic renal failure (CHF) and subclinical carotid atherosclerosis (SCA). Fifty seven individuals (86.4%) had presented some aggravating risk factors, and MS was the most frequent (68.2%), followed by LVH (34.9%), high CPRus (27.3%), SCA (25.8%), FHCHD (16.7%) and CHF (15.2%). After the reclassification, eight patients (12.1%) were of low risk, 36 (54.6%) of intermediate risk and 22 (33.3%) of high CDV risk. The combined diagnosis of MS and FHCHD was the less expensive strategy of reclassification, changing the risk of 48 patients (72.2%) with a cost of US$ 4,60 per each reclassified individual. The most expensive (US$ 327,52 each patient) was the isolated diagnostic of SCA, that changed the risk of only 17 patients (25.8%). Therefore, FRS underestimated CDV risk in the majority of the evaluated patients, because the frequency of risk enhancers was high, especially metabolic syndrome. Combined screening of the aggravating risk factors seems to be the better strategy. However, this screening must be individualized so as not to have unnecessary expenses. |
id |
UFS-2_35945a2e826f3a9d516ef226b0f57af4 |
---|---|
oai_identifier_str |
oai:ufs.br:riufs/3679 |
network_acronym_str |
UFS-2 |
network_name_str |
Repositório Institucional da UFS |
repository_id_str |
|
spelling |
Nascimento, Thiago Augusto Silvahttp://lattes.cnpq.br/1140562731122924Barreto Filho, José Augusto Soareshttp://lattes.cnpq.br/51230323975816382017-09-26T12:16:37Z2017-09-26T12:16:37Z2009-08-20NASCIMENTO, Thiago Augusto Silva. Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes. 2009. 52 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Sergipe, Aracaju, 2009.https://ri.ufs.br/handle/riufs/3679Coronary heart disease (CHD) is one of the main causes of death in the world and Framingham Risk Score (FRS) is the most used tool to assess the risk of CHD in asymptomatic patients. However, it underestimates the cardiovascular (CDV) risk in some individuals. To address this problem, Brazilian Society of Cardiology proposes further risk stratification tests, using emerging risk factors - known as aggravating risk factors - that, when present, reclassify the risk category to a higher one than that initially estimated by the FRS. One does not know which of these aggravating risk factors have more influence in this reclassification, nor the frequency of each CDV risk category after their use and its financial cost. In an observational, descriptive study, 66 patients (54,8 ± 13,9 years, 33 men and 33 women) from a private clinic at Aracaju, Sergipe, had been evaluated during their routine medical exams. Forty three (65.2%) patients were at low-risk category and 23 (34.8%) at the intermediate risk. All of them had been submitted to the screening of the following aggravating risk factors: familiar history of premature CHD (FHCHD), metabolic syndrome (MS), left ventricular hypertrophy (LVH), high sensitivity C reactive protein (CPRus), chronic renal failure (CHF) and subclinical carotid atherosclerosis (SCA). Fifty seven individuals (86.4%) had presented some aggravating risk factors, and MS was the most frequent (68.2%), followed by LVH (34.9%), high CPRus (27.3%), SCA (25.8%), FHCHD (16.7%) and CHF (15.2%). After the reclassification, eight patients (12.1%) were of low risk, 36 (54.6%) of intermediate risk and 22 (33.3%) of high CDV risk. The combined diagnosis of MS and FHCHD was the less expensive strategy of reclassification, changing the risk of 48 patients (72.2%) with a cost of US$ 4,60 per each reclassified individual. The most expensive (US$ 327,52 each patient) was the isolated diagnostic of SCA, that changed the risk of only 17 patients (25.8%). Therefore, FRS underestimated CDV risk in the majority of the evaluated patients, because the frequency of risk enhancers was high, especially metabolic syndrome. Combined screening of the aggravating risk factors seems to be the better strategy. However, this screening must be individualized so as not to have unnecessary expenses.A doença arterial coronariana (DAC) é uma das principais causas de morte no mundo e o Escore de Risco de Framingham (ERF) é uma das ferramentas mais utilizada para identificar indivíduos assintomáticos predispostos a essa patologia. Entretanto, ele subestima o risco cardiovascular (CDV) em determinados pacientes. Para contornar esse problema, a Sociedade Brasileira de Cardiologia preconiza a pesquisa de algumas variáveis clínicas e laboratoriais - conhecidas como critérios agravantes de risco que, quando presentes, reclassificam os pacientes numa categoria de risco superior aquela inicialmente estimada pelo ERF. Não se sabe quais dos critérios agravantes propostos têm maior influência nessa reclassificação, a freqüência de cada faixa de risco CDV nem o custo financeiro após a utilização desses agravantes. Trata-se de um estudo observacional, descritivo, foram avaliados 66 indivíduos com idade média de 54,8 ± 13,9 anos, atendidos em um serviço privado de Aracaju, Sergipe, para check-up cardiológico rotineiro. Eram 43 (65,2%) pacientes de baixo e 23 (34,8%) de médio risco pelo ERF, sendo 33 homens e 33 mulheres. Todos foram submetidos à pesquisa dos seguintes critérios agravantes: história familiar de DAC precoce (HFDAC), síndrome metabólica (SM), hipertrofia ventricular esquerda (HVE), proteína C reativa de alta sensibilidade elevada (PCRas), insuficiência renal crônica (IRC) e aterosclerose subclínica de carótidas (ATCL). Cinqüenta e sete indivíduos (86,4%) apresentaram algum agravante de risco, sendo a SM o mais frequente (68,2%), seguida pela HVE (34,9%), PCRas elevada (27,3%), ATCL (25,8%), HFDAC (16,7%) e IRC (15,2%). Após a reclassificação, oito pacientes (12,1%) eram de baixo risco, 36 (54,6%) de médio risco e 22 (33,3%) de alto risco CDV. A pesquisa combinada de SM e HFDAC foi a estratégia mais barata de reestratificação, mudando o risco de 48 pacientes (72,2%) a um custo de US$ 4,60 por indivíduo reclassificado. A mais cara (US$ 327,52 por paciente) foi a investigação isolada de ATCL, que mudou a categoria do risco em apenas 17 pessoas (25,8%). Em suma, o ERF subestimou o risco CDV na maioria dos pacientes estudados devido à elevada freqüência de critérios agravantes. Todavia, a solicitação de exames deve ser criteriosa para que não haja gastos desnecessários. A pesquisa combinada de SM e HFDAC foi a estratégia com melhor relação custo benefício.application/pdfporUniversidade Federal de SergipePós-Graduação em Ciências da SaúdeUFSBRDoença arterial coronarianaEscore de risco de FraminghamSíndrome metabólicaCoronary heart diseaseFramingham risk scoreMetabolic syndromeCNPQ::CIENCIAS DA SAUDE::MEDICINAReclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantesESTIMATED RISK OF CARDIOVASCULAR REGRADING BY THE FRAMINGHAM SCORE USING THE CONCEPT OF CRITERIA AGGRAVATINGinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFSinstname:Universidade Federal de Sergipe (UFS)instacron:UFSTEXTTHIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf.txtTHIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf.txtExtracted texttext/plain93118https://ri.ufs.br/jspui/bitstream/riufs/3679/2/THIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf.txtc6e96b7f4d90a7061b5d34dd74e860b7MD52THUMBNAILTHIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf.jpgTHIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf.jpgGenerated Thumbnailimage/jpeg1307https://ri.ufs.br/jspui/bitstream/riufs/3679/3/THIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf.jpg27584a60cd55766a1480a8ed28b00028MD53ORIGINALTHIAGO_AUGUSTO_SILVA_NASCIMENTO.pdfapplication/pdf443344https://ri.ufs.br/jspui/bitstream/riufs/3679/1/THIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf45df4211eb77491742b5c6641286277bMD51riufs/36792017-11-28 17:00:52.845oai:ufs.br:riufs/3679Repositório InstitucionalPUBhttps://ri.ufs.br/oai/requestrepositorio@academico.ufs.bropendoar:2017-11-28T20:00:52Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)false |
dc.title.por.fl_str_mv |
Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes |
dc.title.alternative.eng.fl_str_mv |
ESTIMATED RISK OF CARDIOVASCULAR REGRADING BY THE FRAMINGHAM SCORE USING THE CONCEPT OF CRITERIA AGGRAVATING |
title |
Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes |
spellingShingle |
Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes Nascimento, Thiago Augusto Silva Doença arterial coronariana Escore de risco de Framingham Síndrome metabólica Coronary heart disease Framingham risk score Metabolic syndrome CNPQ::CIENCIAS DA SAUDE::MEDICINA |
title_short |
Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes |
title_full |
Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes |
title_fullStr |
Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes |
title_full_unstemmed |
Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes |
title_sort |
Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes |
author |
Nascimento, Thiago Augusto Silva |
author_facet |
Nascimento, Thiago Augusto Silva |
author_role |
author |
dc.contributor.author.fl_str_mv |
Nascimento, Thiago Augusto Silva |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/1140562731122924 |
dc.contributor.advisor1.fl_str_mv |
Barreto Filho, José Augusto Soares |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/5123032397581638 |
contributor_str_mv |
Barreto Filho, José Augusto Soares |
dc.subject.por.fl_str_mv |
Doença arterial coronariana Escore de risco de Framingham Síndrome metabólica |
topic |
Doença arterial coronariana Escore de risco de Framingham Síndrome metabólica Coronary heart disease Framingham risk score Metabolic syndrome CNPQ::CIENCIAS DA SAUDE::MEDICINA |
dc.subject.eng.fl_str_mv |
Coronary heart disease Framingham risk score Metabolic syndrome |
dc.subject.cnpq.fl_str_mv |
CNPQ::CIENCIAS DA SAUDE::MEDICINA |
description |
Coronary heart disease (CHD) is one of the main causes of death in the world and Framingham Risk Score (FRS) is the most used tool to assess the risk of CHD in asymptomatic patients. However, it underestimates the cardiovascular (CDV) risk in some individuals. To address this problem, Brazilian Society of Cardiology proposes further risk stratification tests, using emerging risk factors - known as aggravating risk factors - that, when present, reclassify the risk category to a higher one than that initially estimated by the FRS. One does not know which of these aggravating risk factors have more influence in this reclassification, nor the frequency of each CDV risk category after their use and its financial cost. In an observational, descriptive study, 66 patients (54,8 ± 13,9 years, 33 men and 33 women) from a private clinic at Aracaju, Sergipe, had been evaluated during their routine medical exams. Forty three (65.2%) patients were at low-risk category and 23 (34.8%) at the intermediate risk. All of them had been submitted to the screening of the following aggravating risk factors: familiar history of premature CHD (FHCHD), metabolic syndrome (MS), left ventricular hypertrophy (LVH), high sensitivity C reactive protein (CPRus), chronic renal failure (CHF) and subclinical carotid atherosclerosis (SCA). Fifty seven individuals (86.4%) had presented some aggravating risk factors, and MS was the most frequent (68.2%), followed by LVH (34.9%), high CPRus (27.3%), SCA (25.8%), FHCHD (16.7%) and CHF (15.2%). After the reclassification, eight patients (12.1%) were of low risk, 36 (54.6%) of intermediate risk and 22 (33.3%) of high CDV risk. The combined diagnosis of MS and FHCHD was the less expensive strategy of reclassification, changing the risk of 48 patients (72.2%) with a cost of US$ 4,60 per each reclassified individual. The most expensive (US$ 327,52 each patient) was the isolated diagnostic of SCA, that changed the risk of only 17 patients (25.8%). Therefore, FRS underestimated CDV risk in the majority of the evaluated patients, because the frequency of risk enhancers was high, especially metabolic syndrome. Combined screening of the aggravating risk factors seems to be the better strategy. However, this screening must be individualized so as not to have unnecessary expenses. |
publishDate |
2009 |
dc.date.issued.fl_str_mv |
2009-08-20 |
dc.date.accessioned.fl_str_mv |
2017-09-26T12:16:37Z |
dc.date.available.fl_str_mv |
2017-09-26T12:16:37Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
NASCIMENTO, Thiago Augusto Silva. Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes. 2009. 52 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Sergipe, Aracaju, 2009. |
dc.identifier.uri.fl_str_mv |
https://ri.ufs.br/handle/riufs/3679 |
identifier_str_mv |
NASCIMENTO, Thiago Augusto Silva. Reclassificação do risco cardiovascular estimado pelo Escore de Framingham utilizando o conceito dos critérios agravantes. 2009. 52 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Sergipe, Aracaju, 2009. |
url |
https://ri.ufs.br/handle/riufs/3679 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Sergipe |
dc.publisher.program.fl_str_mv |
Pós-Graduação em Ciências da Saúde |
dc.publisher.initials.fl_str_mv |
UFS |
dc.publisher.country.fl_str_mv |
BR |
publisher.none.fl_str_mv |
Universidade Federal de Sergipe |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFS instname:Universidade Federal de Sergipe (UFS) instacron:UFS |
instname_str |
Universidade Federal de Sergipe (UFS) |
instacron_str |
UFS |
institution |
UFS |
reponame_str |
Repositório Institucional da UFS |
collection |
Repositório Institucional da UFS |
bitstream.url.fl_str_mv |
https://ri.ufs.br/jspui/bitstream/riufs/3679/2/THIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf.txt https://ri.ufs.br/jspui/bitstream/riufs/3679/3/THIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf.jpg https://ri.ufs.br/jspui/bitstream/riufs/3679/1/THIAGO_AUGUSTO_SILVA_NASCIMENTO.pdf |
bitstream.checksum.fl_str_mv |
c6e96b7f4d90a7061b5d34dd74e860b7 27584a60cd55766a1480a8ed28b00028 45df4211eb77491742b5c6641286277b |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS) |
repository.mail.fl_str_mv |
repositorio@academico.ufs.br |
_version_ |
1802110748406579200 |